Scarica l'app Stockscreener
14.79
9.04%
-1.47
Dopo l'orario di chiusura:
14.77
-0.02
-0.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Axogen Inc Borsa (AXGN) Ultime notizie
Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin - Yahoo Finance
AxoGen price target lowered to $20 from $21 at Raymond James - MSN
How Axogen Inc. stock performs during market volatility - sundaytimes.kr
Can Axogen Inc. grow without external funding2025 Market Overview & Expert-Curated Trade Recommendations - classian.co.kr
Does Axogen Inc. fit your quant trading modelEntry Point & Advanced Technical Signal Analysis - Newser
Tools to assess Axogen Inc.’s risk profileMarket Weekly Review & Expert Curated Trade Ideas - Newser
Short interest data insights for Axogen Inc.Watch List & Fast Entry Momentum Alerts - Newser
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21 - MSN
Full technical analysis of Axogen Inc. stockWeekly Trade Review & High Win Rate Trade Alerts - Newser
How to read the order book for Axogen Inc.2025 Price Action Summary & Intraday High Probability Setup Alerts - Newser
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know - MSN
Will Axogen Inc. outperform its industry peersTrade Risk Assessment & Weekly Breakout Stock Alerts - newsyoung.net
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Nigeria
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com India
Axogen Inc. Recovery Likely Here’s What Data ShowsJuly 2025 Weekly Recap & Community Shared Stock Ideas - metal.it
Axogen Inc. stock retracement – recovery analysis2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
Axogen's Strategic Position in the Evolving Peripheral Nerve Repair Market: A Deep Dive into Clinical Success, Regulatory Momentum, and Growth Potential - AInvest
Axogen: Broad Range Of Outcomes Still Present, Opting To Remain Sidelined - Seeking Alpha
Cantor Fitzgerald reiterates Overweight rating on AxoGen stock after strong Q2 By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight rating on AxoGen stock after strong Q2 - Investing.com
Zurcher Kantonalbank Zurich Cantonalbank Invests $146,000 in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
IBD Rating Upgrades: Axogen Shows Improved Price Strength - Investor's Business Daily
Leading vs lagging indicators on Axogen Inc. performanceTrade Alert System with Volume Analysis - Newser
How high can Axogen Inc. stock goSector Rotation Outlook With Historical Summary - Newser
Price momentum metrics for Axogen Inc. explainedFree Real Time Stock Movement Analysis - Newser
Axogen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
FY2025 EPS Estimates for AxoGen Raised by Cantor Fitzgerald - Defense World
Is now a turning point for Axogen Inc.Market Forecast Summary Over Multi-Year Period - Newser
AxoGen (NASDAQ:AXGN) Upgraded to Buy at Wall Street Zen - Defense World
Can volume confirm reversal in Axogen Inc.Low Drawdown Picks with Weekly Updates - Newser
Ichimoku Cloud Indicates Uncertainty Around Axogen Inc.Expert Verified Stock Trade Ideas Backed by Data - beatles.ru
Axogen Inc Reports Strong Q2 2025 Earnings with 18.3% Revenue Growth and BLA Approval Expected in September - AInvest
AxoGen’s Earnings Call: Strong Growth Amid Challenges - The Globe and Mail
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates - NewsBreak: Local News & Alerts
Axogen 2025 Q2 Earnings Returns to Profitability with 130.1% Net Income Jump - AInvest
Axogen raises 2025 revenue growth target to at least 17% as BLA approval nears - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q2 2025 Earnings Call Transcript - Insider Monkey
Axogen Reports Strong Q2 2025 Financial Results - The Globe and Mail
How to build a custom watchlist for Axogen Inc.Free Stock Selection With High Accuracy - Newser
AxoGen: Q2 Earnings Snapshot - Stamford Advocate
Axogen Inc (AXGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Risk adjusted return profile for Axogen Inc. analyzedRisk-Managed Swing Setup and Signal Analysis - Newser
Axogen, Inc. Reports Strong Revenue Growth in Q2 2025 - TipRanks
Axogen (AXGN) Q2 Revenue Jumps 18% - AOL.com
AxoGen stock price target lowered to $20 by Raymond James on BLA timing - Investing.com Nigeria
Axogen (AXGN.O) Sees Sharp Intraday Move—What's Driving the Volatility? - AInvest
AxoGen reports Q2 adjusted EPS 12c, consensus 6c - TipRanks
AxoGen Q2 2025 Earnings Call Transcript - MarketBeat
Jefferies raises AxoGen stock price target to $25 on strong sales growth - Investing.com India
Jefferies raises AxoGen stock price target to $25 on strong sales growth By Investing.com - Investing.com South Africa
Axogen's Q2 2025 Earnings Call: Unpacking Contradictions in Margins, BLA Milestones, and Growth Strategies - AInvest
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):